Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Kimberly Jordan

Concepts (326)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ovarian Neoplasms
9
2026
604
1.490
Why?
Tumor Microenvironment
12
2026
747
1.330
Why?
T-Lymphocytes
12
2026
2012
1.230
Why?
Cancer Vaccines
7
2021
161
1.100
Why?
Myeloid-Derived Suppressor Cells
6
2026
78
1.080
Why?
Antineoplastic Combined Chemotherapy Protocols
7
2025
1998
0.810
Why?
Antigens, Neoplasm
6
2021
271
0.720
Why?
Receptors, Antigen, T-Cell
7
2021
677
0.660
Why?
Focal Adhesion Protein-Tyrosine Kinases
1
2020
34
0.650
Why?
Baculoviridae
3
2009
44
0.610
Why?
Cytoreduction Surgical Procedures
1
2020
69
0.610
Why?
Chemotherapy, Adjuvant
1
2020
429
0.570
Why?
Image Processing, Computer-Assisted
1
2023
778
0.570
Why?
Insecta
3
2009
73
0.550
Why?
Neoadjuvant Therapy
2
2022
475
0.540
Why?
Extracellular Vesicles
1
2020
176
0.530
Why?
Melanoma
4
2023
765
0.500
Why?
Colorectal Neoplasms
4
2025
874
0.500
Why?
Granulocytes
1
2017
82
0.490
Why?
Pancreatic Cyst
1
2017
50
0.480
Why?
Lymphocyte Activation
4
2017
1137
0.470
Why?
Monocytes
2
2020
538
0.430
Why?
Poly(ADP-ribose) Polymerase Inhibitors
3
2025
139
0.430
Why?
Spleen
1
2017
503
0.420
Why?
Vaccines
2
2010
389
0.420
Why?
CD8-Positive T-Lymphocytes
7
2024
931
0.420
Why?
Cystadenocarcinoma, Serous
2
2026
90
0.420
Why?
Xenograft Model Antitumor Assays
8
2025
930
0.410
Why?
Programmed Cell Death 1 Receptor
3
2022
268
0.410
Why?
Myeloid Cells
2
2020
149
0.390
Why?
Neoplasms
6
2017
2954
0.390
Why?
Vaccines, Subunit
2
2012
53
0.380
Why?
Cell Line, Tumor
11
2026
3545
0.380
Why?
Tomography, X-Ray Computed
1
2023
2786
0.370
Why?
Histone-Lysine N-Methyltransferase
2
2024
141
0.370
Why?
Mice, Inbred BALB C
10
2026
1244
0.360
Why?
Complementarity Determining Regions
1
2012
54
0.350
Why?
Antigens, CD19
2
2026
137
0.350
Why?
Mice
26
2026
18297
0.340
Why?
Gamma Rays
2
2021
56
0.320
Why?
Benzimidazoles
2
2024
191
0.320
Why?
Antibodies, Monoclonal, Humanized
4
2025
992
0.300
Why?
Antineoplastic Agents, Immunological
4
2020
200
0.300
Why?
Immunotherapy, Adoptive
2
2026
356
0.280
Why?
Inflammation
1
2020
2919
0.280
Why?
Female
33
2026
79499
0.270
Why?
CD47 Antigen
2
2025
41
0.270
Why?
H-2 Antigens
1
2008
111
0.260
Why?
Breast Neoplasms
1
2020
2418
0.260
Why?
Immunotherapy
5
2021
671
0.260
Why?
Pancreatic Neoplasms
3
2021
944
0.260
Why?
Animals
29
2026
38107
0.250
Why?
Cell Proliferation
7
2024
2502
0.250
Why?
Antigens
1
2009
350
0.250
Why?
Carcinoma, Pancreatic Ductal
2
2021
297
0.250
Why?
Drug Resistance, Neoplasm
4
2025
893
0.250
Why?
Proteome
2
2022
520
0.240
Why?
Peptide Library
4
2013
91
0.240
Why?
Tumor Escape
2
2017
50
0.240
Why?
Receptors, Interleukin-8B
1
2026
29
0.240
Why?
Peptides
4
2021
992
0.240
Why?
Survival Analysis
4
2021
1378
0.240
Why?
Humans
47
2026
146342
0.240
Why?
Disease Models, Animal
6
2026
4580
0.230
Why?
Vaccination
3
2010
1449
0.230
Why?
Granuloma
1
2026
96
0.230
Why?
Lymphocytes, Tumor-Infiltrating
3
2021
156
0.220
Why?
Phthalazines
1
2025
64
0.220
Why?
Lupus Nephritis
1
2025
67
0.220
Why?
Lung Neoplasms
3
2024
2675
0.220
Why?
Transcriptome
2
2022
1068
0.210
Why?
Class I Phosphatidylinositol 3-Kinases
1
2025
111
0.210
Why?
Models, Biological
2
2021
1761
0.210
Why?
Major Histocompatibility Complex
4
2021
234
0.210
Why?
Lymphoma, B-Cell
1
2026
150
0.210
Why?
Keratins
1
2024
57
0.210
Why?
Tryptophan Oxygenase
1
2024
33
0.200
Why?
Bevacizumab
1
2024
169
0.200
Why?
Interferons
2
2022
186
0.200
Why?
beta Catenin
1
2025
250
0.200
Why?
Signal-To-Noise Ratio
1
2023
71
0.190
Why?
Neoplasms, Experimental
2
2021
163
0.190
Why?
Piperazines
1
2025
368
0.190
Why?
Disease Progression
5
2026
2867
0.190
Why?
Tuberculosis
1
2026
290
0.190
Why?
Fallopian Tubes
1
2022
33
0.190
Why?
Mycobacterium tuberculosis
1
2026
325
0.190
Why?
Artifacts
1
2023
143
0.190
Why?
Prognosis
5
2024
4351
0.180
Why?
Dendritic Cells
4
2020
509
0.180
Why?
Ephrin-B2
2
2021
45
0.180
Why?
Carcinoma, Non-Small-Cell Lung
2
2022
1195
0.180
Why?
Small Cell Lung Carcinoma
1
2024
125
0.180
Why?
Macrophages
3
2026
1532
0.180
Why?
Fibrosis
2
2024
568
0.180
Why?
Middle Aged
13
2026
36619
0.180
Why?
Neoplasms, Second Primary
1
2023
103
0.170
Why?
Tretinoin
2
2023
115
0.170
Why?
Flow Cytometry
5
2022
1163
0.170
Why?
Blood
1
2022
107
0.170
Why?
Mycosis Fungoides
1
2021
63
0.170
Why?
Gene Expression Profiling
3
2021
1792
0.170
Why?
ADAM10 Protein
1
2021
29
0.160
Why?
Ovary
1
2022
236
0.160
Why?
Precision Medicine
1
2025
462
0.160
Why?
Synovial Membrane
1
2022
130
0.160
Why?
Seroconversion
1
2021
48
0.160
Why?
Amyloid Precursor Protein Secretases
1
2021
80
0.160
Why?
Proteomics
3
2024
1203
0.160
Why?
Databases, Genetic
1
2021
239
0.150
Why?
Oligonucleotides, Antisense
1
2020
122
0.150
Why?
Eosinophilic Esophagitis
1
2024
333
0.150
Why?
Immunity
1
2020
141
0.150
Why?
Splenectomy
1
2020
61
0.150
Why?
Radiation Injuries
1
2021
149
0.150
Why?
Diagnostic Imaging
1
2022
340
0.150
Why?
Cell Adhesion
1
2020
447
0.140
Why?
Case-Control Studies
3
2022
3647
0.140
Why?
Receptor, EphB4
1
2019
33
0.140
Why?
Neoplasm Invasiveness
1
2020
504
0.140
Why?
Epithelial-Mesenchymal Transition
1
2021
219
0.140
Why?
Adrenal Cortex Neoplasms
1
2020
70
0.140
Why?
Survival Rate
2
2021
2092
0.140
Why?
Adrenocortical Carcinoma
1
2020
72
0.140
Why?
STAT3 Transcription Factor
1
2020
214
0.140
Why?
Multiple Sclerosis
1
2024
435
0.140
Why?
Radiosurgery
1
2022
398
0.140
Why?
Cell Communication
1
2020
327
0.140
Why?
Isoxazoles
1
2018
57
0.140
Why?
T-Lymphocytes, Regulatory
3
2020
415
0.140
Why?
Papillomavirus Infections
1
2022
345
0.140
Why?
Interferon-alpha
1
2019
201
0.140
Why?
Adult
10
2026
41087
0.140
Why?
Autoantigens
1
2021
426
0.140
Why?
Ipilimumab
1
2018
44
0.140
Why?
Mice, Transgenic
3
2024
2134
0.130
Why?
Immunophenotyping
3
2017
324
0.130
Why?
Biomarkers, Tumor
2
2022
1339
0.130
Why?
Metabolome
1
2021
390
0.130
Why?
Colonic Neoplasms
2
2012
259
0.130
Why?
Drug Discovery
1
2018
154
0.130
Why?
Head and Neck Neoplasms
1
2022
563
0.130
Why?
Lymphoma, Non-Hodgkin
1
2018
124
0.130
Why?
Combined Modality Therapy
1
2020
1271
0.130
Why?
Histone Deacetylase Inhibitors
1
2019
219
0.130
Why?
Aged
8
2026
26432
0.120
Why?
Oxidation-Reduction
1
2020
1075
0.120
Why?
Problem-Based Learning
1
2017
99
0.120
Why?
Spodoptera
2
2021
39
0.120
Why?
Students, Pharmacy
1
2017
96
0.120
Why?
Cell Count
1
2017
315
0.120
Why?
Adipose Tissue
1
2020
642
0.120
Why?
Triple Negative Breast Neoplasms
1
2019
220
0.120
Why?
Algorithms
1
2023
1849
0.110
Why?
Cytotoxicity, Immunologic
2
2020
224
0.110
Why?
Signal Transduction
4
2024
5246
0.110
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2018
299
0.110
Why?
Multiple Myeloma
1
2018
310
0.110
Why?
Neoplasm Recurrence, Local
1
2021
1160
0.110
Why?
Perception
1
2017
373
0.110
Why?
Tumor Cells, Cultured
3
2021
882
0.110
Why?
Membrane Proteins
1
2021
1130
0.100
Why?
Skin Neoplasms
1
2021
806
0.100
Why?
Male
13
2026
73396
0.100
Why?
Mice, Nude
3
2020
668
0.100
Why?
Liver Neoplasms
1
2020
776
0.100
Why?
Blood Cell Count
1
2013
56
0.100
Why?
Prostatic Neoplasms
1
2020
972
0.100
Why?
Lipopolysaccharide Receptors
1
2013
88
0.090
Why?
Arthritis, Rheumatoid
1
2022
1185
0.090
Why?
Immunohistochemistry
3
2022
1712
0.090
Why?
Interferon-gamma
2
2021
781
0.090
Why?
Apoptosis
4
2024
2439
0.090
Why?
Down Syndrome
1
2019
529
0.090
Why?
Young Adult
3
2021
14330
0.090
Why?
Suppressor Factors, Immunologic
1
2011
4
0.090
Why?
Epitopes, T-Lymphocyte
1
2012
175
0.090
Why?
Cells, Cultured
2
2017
4118
0.080
Why?
Datasets as Topic
2
2022
120
0.080
Why?
B7-H1 Antigen
2
2024
245
0.080
Why?
Follow-Up Studies
1
2020
5439
0.080
Why?
Neoplasm Proteins
1
2013
444
0.080
Why?
Transcription Factors
1
2018
1730
0.080
Why?
Curriculum
1
2017
1079
0.080
Why?
Immunodominant Epitopes
1
2010
27
0.080
Why?
Biomarkers
4
2024
4340
0.080
Why?
Neoplasm Staging
1
2013
1488
0.070
Why?
Genes, MHC Class I
1
2009
37
0.070
Why?
Gene Expression Regulation, Neoplastic
2
2025
1432
0.070
Why?
Genetic Engineering
1
2009
89
0.070
Why?
Cell Survival
2
2024
1105
0.070
Why?
Histocompatibility Antigens Class I
1
2010
207
0.070
Why?
Histocompatibility Antigen H-2D
1
2008
20
0.070
Why?
Complement System Proteins
2
2022
326
0.070
Why?
Cross-Priming
1
2008
17
0.070
Why?
CD11c Antigen
1
2008
40
0.070
Why?
Adjuvants, Immunologic
1
2009
245
0.060
Why?
Neutrophils
2
2026
1133
0.060
Why?
Molecular Targeted Therapy
2
2020
447
0.060
Why?
RNA, Messenger
3
2024
2791
0.060
Why?
Cell Culture Techniques
1
2009
371
0.060
Why?
Bacterial Load
1
2026
68
0.060
Why?
Mice, Inbred C3H
1
2026
252
0.060
Why?
Gene Expression
2
2022
1463
0.060
Why?
Nephrocalcinosis
1
2025
12
0.060
Why?
Phenylurea Compounds
1
2026
122
0.060
Why?
Aged, 80 and over
2
2020
8391
0.060
Why?
Microsatellite Instability
1
2025
57
0.060
Why?
Immune Tolerance
1
2008
386
0.060
Why?
Adolescent
2
2025
22557
0.060
Why?
Cetuximab
1
2025
110
0.060
Why?
Drug Synergism
1
2025
354
0.050
Why?
Ligands
2
2022
678
0.050
Why?
Cisplatin
1
2026
347
0.050
Why?
Cancer-Associated Fibroblasts
1
2024
23
0.050
Why?
Cell Line
1
2010
2814
0.050
Why?
Histocompatibility Antigens
1
2024
102
0.050
Why?
Neuroendocrine Cells
1
2024
34
0.050
Why?
Wnt Signaling Pathway
1
2025
211
0.050
Why?
Microsatellite Repeats
1
2024
159
0.050
Why?
Neoplasm Grading
1
2024
313
0.050
Why?
Cell Differentiation
1
2011
1982
0.050
Why?
Kynurenine
1
2024
114
0.050
Why?
Recombinant Fusion Proteins
1
2025
663
0.050
Why?
Imidazoles
1
2024
245
0.050
Why?
Tryptophan
1
2024
184
0.050
Why?
Neuroendocrine Tumors
1
2024
122
0.050
Why?
Mice, Inbred C57BL
3
2021
6034
0.040
Why?
Desmin
1
2002
22
0.040
Why?
Myofibrils
1
2002
55
0.040
Why?
Sf9 Cells
1
2021
11
0.040
Why?
Lymphocytes
2
2020
379
0.040
Why?
Feasibility Studies
1
2026
1135
0.040
Why?
Autophagy
1
2024
290
0.040
Why?
Tissue Distribution
1
2022
334
0.040
Why?
Hypoalbuminemia
1
2021
26
0.040
Why?
Access to Information
1
2021
46
0.040
Why?
Cell- and Tissue-Based Therapy
1
2021
82
0.040
Why?
Ranolazine
1
2020
23
0.040
Why?
Animals, Genetically Modified
1
2002
248
0.040
Why?
Carcinogenesis
1
2022
226
0.040
Why?
Cluster Analysis
1
2022
496
0.040
Why?
Seroepidemiologic Studies
1
2021
171
0.040
Why?
Data Mining
1
2021
113
0.040
Why?
Enzyme Inhibitors
1
2024
823
0.040
Why?
Receptors, CCR
1
2020
6
0.040
Why?
Cytokines
3
2018
2081
0.040
Why?
Platelet Count
1
2020
95
0.040
Why?
Basophils
1
2020
52
0.040
Why?
Lymphocyte Subsets
1
2020
79
0.040
Why?
RNA, Viral
1
2024
693
0.040
Why?
Hematopoiesis
1
2021
195
0.040
Why?
Interleukin-6
1
2024
784
0.040
Why?
Tumor Burden
1
2020
326
0.040
Why?
Leukocyte Count
1
2020
321
0.040
Why?
Autoimmunity
1
2025
925
0.040
Why?
Mutation
1
2010
4093
0.040
Why?
Swine
1
2002
821
0.040
Why?
Postoperative Period
1
2020
355
0.040
Why?
Pancreaticoduodenectomy
1
2020
149
0.040
Why?
Biological Availability
1
2018
146
0.030
Why?
Immunoglobulin G
1
2003
901
0.030
Why?
Automation
1
2018
104
0.030
Why?
Gene Knockdown Techniques
1
2019
335
0.030
Why?
Killer Cells, Natural
1
2021
481
0.030
Why?
Radiotherapy
1
2019
209
0.030
Why?
Complement Activation
1
2021
412
0.030
Why?
Inpatients
1
2022
540
0.030
Why?
Structure-Activity Relationship
1
2018
563
0.030
Why?
Kidney
1
2025
1498
0.030
Why?
Molecular Structure
1
2018
484
0.030
Why?
B-Lymphocytes
1
2003
887
0.030
Why?
Lipid Metabolism
1
2020
533
0.030
Why?
Protein Domains
1
2018
315
0.030
Why?
Homeostasis
1
2021
646
0.030
Why?
Aging
1
2008
1996
0.030
Why?
Drug Delivery Systems
1
2020
377
0.030
Why?
Cell Movement
1
2021
951
0.030
Why?
Administration, Oral
1
2018
872
0.030
Why?
Comorbidity
1
2021
1665
0.030
Why?
Education, Pharmacy
1
2017
125
0.030
Why?
Metabolomics
1
2021
738
0.030
Why?
Antibodies, Monoclonal
1
2022
1512
0.030
Why?
Dose-Response Relationship, Drug
1
2018
2022
0.030
Why?
Educational Measurement
1
2017
331
0.030
Why?
Severity of Illness Index
1
2022
2921
0.030
Why?
Program Evaluation
1
2017
952
0.020
Why?
Lung
1
2026
4122
0.020
Why?
Cross Reactions
1
2012
130
0.020
Why?
Antineoplastic Agents
1
2024
2219
0.020
Why?
Retrospective Studies
2
2021
17438
0.020
Why?
Muscle, Skeletal
1
2002
1818
0.020
Why?
Indoleamine-Pyrrole 2,3,-Dioxygenase
1
2011
56
0.020
Why?
Culture Media, Conditioned
1
2011
112
0.020
Why?
Enzyme-Linked Immunosorbent Assay
1
2012
846
0.020
Why?
Endocytosis
1
2011
170
0.020
Why?
Hospitalization
1
2021
2475
0.020
Why?
Universities
1
2013
451
0.020
Why?
In Vitro Techniques
1
2011
1041
0.020
Why?
Treatment Outcome
1
2024
11821
0.020
Why?
Prospective Studies
1
2021
8123
0.020
Why?
Mice, Knockout
2
2008
3125
0.020
Why?
Enterotoxins
1
2006
89
0.010
Why?
T-Lymphocytes, Cytotoxic
1
2006
180
0.010
Why?
DNA Primers
1
2006
487
0.010
Why?
Drug Design
1
2006
180
0.010
Why?
Antigen Presentation
1
2006
209
0.010
Why?
Blood Cells
1
2003
38
0.010
Why?
CD40 Ligand
1
2003
32
0.010
Why?
Colorado
1
2013
4595
0.010
Why?
Coculture Techniques
1
2003
245
0.010
Why?
Amino Acid Sequence
1
2006
2092
0.010
Why?
Toes
1
2002
16
0.010
Why?
Molecular Sequence Data
1
2006
2838
0.010
Why?
Sarcomeres
1
2002
100
0.010
Why?
Antibody Formation
1
2003
290
0.010
Why?
Child
1
2021
22693
0.010
Why?
Microscopy, Electron
1
2002
384
0.010
Why?
Immunoglobulins
1
2002
162
0.010
Why?
Organ Size
1
2002
465
0.010
Why?
Cattle
1
2003
940
0.010
Why?
Echocardiography
1
2002
645
0.010
Why?
Birth Weight
1
2002
521
0.010
Why?
Biomechanical Phenomena
1
2002
874
0.010
Why?
Placenta
1
2002
794
0.010
Why?
Phenotype
1
2002
3206
0.010
Why?
Jordan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)